News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Federal Circuit Again Invalidates Johnson & Johnson (JNJ)'s Cordis Corporation (JNJ) Patent Claims Against Medtronic, Inc. (MDT), Abbott Laboratories (ABT), Boston Scientific Corporation (BSX)


6/28/2013 8:42:58 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Johnson & Johnson subsidiary Cordis Corp. and Pfizer subsidiary Wyeth Pharma. fail to reserve a lower court's rulings invalidating patents for drug-eluting coronary stent technology.A trio of medical device giants notched another win against Johnson & Johnson(NYSE:JNJ) after a Federal Circuit judge upheld a lower court's ruling that invalidated stent patents held by J&J subsidiary Cordis Corp. Device makers Abbott (NYSE:ABT), Boston Scientific (NYSE:BSX) and Medtronic (NYSE:MDT) cemented their previous win the in long-running battle over drug-eluting stent technology and a coating drug called rapamycin.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES